Print
EmailPrescribeIT® is currently live in numerous jurisdictions across the country and is the most advanced example of Pan-Canadian interoperable digital health care. PrescribeIT® is helping support provinces and territories achieve critical health priorities by seamlessly exchanging prescription data, reducing costs, improving patient privacy, and building equitable access to health care in rural and Indigenous communities.
To meet evolving healthcare needs and build upon the momentum and positive impact of PrescribeIT® on the nation’s connected care landscape, Canada Health Infoway (Infoway) published a Request for Expression of Interest (RFEOI) in May 2024 to explore alternative operational and ownership models for PrescribeIT®. The RFEOI formed part of Infoway’s market research to identify potential partners who can champion e-prescription innovation, drive greater adoption of the service, and support a low-cost structure, benefiting all users of PrescribeIT®.
At the time of release, Infoway aimed to understand and explore a range of potential operational and ownership models. Infoway continues to explore options to determine the best path forward for PrescribeIT® and at this time, its intent is to identify a party or consortium interested in investing in PrescribeIT® through a joint venture, acquisition, or other structure, where the selected partner would operate PrescribeIT® moving forward. Infoway’s goal in undergoing these efforts is to ensure the continued advancement of e-prescribing innovation and adoption across the country. These actions do not impact PrescribeIT®’s operations, including the upcoming introduction of transaction fees starting on January 1, 2025.
Infoway has engaged Pricewaterhouse Coopers LLP (PwC) to assist with the process and structure of this work. Letters of Intent (LOIs) from counterparties are required by December 19, 2024, at 4.00 p.m. (ET). Interested parties are invited to contact Ian Lording (